The new CD14-containing drug enables medical conditions to be treated in which the immune system plays a decisive role. The use of CD14 is proposed in the preparation of drugs for the therapy or prophylaxis of endotoxin-induced conditions (sepsis) or for the treatment of tumours or for the preservation of cell cultures or organ or tissue transplants.
申请公布号
DE4029227(A1)
申请公布日期
1992.03.19
申请号
DE19904029227
申请日期
1990.09.14
申请人
IMTOX GMBH, 1000 BERLIN, DE;SCHUETT, CHRISTINE, PROF. DR.MED., O-2200 GREIFSWALD, DE
发明人
SCHUETT, CHRISTINE, PROF. DR.MED., O-2200 GREIFSWALD, DE;KUNZE, RUDOLF, DR., 1000 BERLIN, DE
